Failing energetics in failing hearts
Tóm tắt
Từ khóa
Tài liệu tham khảo
Ingwall JS: Is cardiac failure a consequence of decreased energy reserve? Circulation 1993, 87:VII58-VII62.
Taegtmeyer H: Energy metabolism of the heart: from basic concepts to clinical applications. Curr Probl Cardiol 1994, 19:59–113.
Opie LH: Substrate and energy metabolism in the heart. In Physiology and pathophysiology of the heart. Edited by Sperelakis N. Boston: Kluwer; 1995:367–384.
Saks VA, Tiivel T, Kay L, et al.: On the regulation of cellular energetics in health and disease. Mol Cell Biochem 1996, 160–161:195–208.
Schwartz K, Mercadier JJ: Molecular and cellular biology of heart failure. Curr Opin Cardiol 1996, 11:227–236.
Mittmann C, Eschenhagen T, Scholz H: Cellular and molecular aspects of contractile dysfunction in heart failure. Cardiovasc Res 1998, 39:267–75.
Shen WQ, Asai K, Uechi M, et al.: Progressive loss of myocardial ATP due to a loss of total purines during the development of heart failure in dogs — a compensatory role for the parallel loss of creatine. Circulation 1999, 100:2113–2118. Comprehensive study of failing heart energetics and compensatory mechanisms.
Tian R, Ingwall JS: Energetic basis for reduced contractile reserve in isolated rat hearts. Am J Physiol 1996, 270:H1207-H1216.
Jennings RB, Murry CE, Reimer KA: Energy metabolism in preconditioned and control myocardium: effect of total ischemia. J Mol Cell Cardiol 1991, 23:1449–1458.
Hassinen IE, Vuorinen KH, Ylitalo K, et al.: Role of cellular energetics in ischemia-reperfusion and ischemic preconditioning of myocardium. Mol Cell Biochem 1998, 184:393–400.
Kloner RA, Bolli R, Marban E, et al.: Medical and cellular implications of stunning, hibernation, and preconditioning. Circulation 1998, 97:1848–1867. Excellent review from a group of experts in the field.
Dzeja PP, Pucar D, Redfield MM, et al.: Reduced activity of enzymes coupling ATP-generating with ATP-consuming processes in the failing myocardium. Mol Cell Biochem 1999, 201:33–40. First description of defects in the catalytic activities of enzymes responsible for intracellular energy communication in failing hearts.
Taegtmeyer H, Goodwin GW, Doenst T, et al.: Substrate metabolism as determinant for post-ischemic functional recovery of the heart. Am J Cardiol 1997, 80:3A-10A.
Lewandowski ED, Yu X, LaNoue KF, et al.: Altered metabolite exchange between subcellular compartments in intact post-ischemic rabbit hearts. Circ Res 1997, 81:165–175.
Zuurbier CJ, van Beek JHGM: Mitochondrial response to heart rate steps in isolated rabbit heart is slowed after myocardial stunning. Circ Res 1997, 81:69–75.
Dzeja PP, Zeleznikar RJ, Goldberg ND: Adenylate kinase: kinetic behavior in intact cells indicates it is integral to multiple cellular processes. Mol Cell Biochem 1998, 84:169–182. Review on the role of phosphotransfer in cellular energy homeostasis, and interrelationships between adenylate kinase, creatine kinase, and glycolytic systems.
Dzeja PP, Terzic A: Phosphotransfer reactions in the regulation of ATP-sensitive K+ channels. FASEB J 1998, 12:523–529. Review on the role of phosphotransfer reactions in promoting cellular energy signaling, including regulation of ATP-sensing processes.
Wiese S, Katz DP, Manner T, et al.: Impact of specific substrate supply on efficiency of cardiac function: an update. Nutrition 1993, 9:495–506.
Takahashi E, Doi K: Regulation of oxygen diffusion in hypoxic isolated cardiac myocytes. Am J Physiol 1996, 271:H1734-H1738.
Godecke A, Flogel U, Zanger K, et al.: Disruption of myoglobin in mice induces multiple compensatory mechanisms. Proc Natl Acad Sci U S A 1999, 96:10495–10500. Original study on myoglobin-deficient transgenic hearts demonstrating the significance of compensatory mechanisms.
Weil J, Eschenhagen T, Magnussen O, et al.: Reduction of myocardial myoglobin in bovine dilated cardiomyopathy. J Mol Cell Cardiol 1997, 29:743–751.
Heinke MY, Wheeler CH, Yan JX, et al.: Changes in myocardial protein expression in pacing-induced canine heart failure. Electrophoresis 1999, 20:2086–2093.
Kammermeier H, Wein B, Gerards P, et al.: Barriers in cardiac substrate supply. Bas Res Cardiol 1985, 80:89–92.
Auffermann W, Wu ST, Parmley WW, et al.: Glycolysis in heart failure: A 31P-NMR and surface fluorometry study. Bas Res Cardiol 1990, 85:342–357.
Askenasy N, Navon G: Intermittent ischemia — energy metabolism, cellular volume regulation, adenosine and insights into preconditioning. J Mol Cell Cardiol 1997, 29:1715–1730.
Stanley WC, Lopaschuk GD, Hall JL, McCormack JG: Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions. Cardiovasc Res 1997, 33:243–257.
Regitz V, Fleck E: Myocardial adenine nucleotide concentrations and myocardial norepinephrine content in patients with heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am J Cardiol 1992, 69: 1574–1580.
McDonald KM, Yoshiyama M, Francis GS, et al.: Myocardial bioenergetic abnormalities in a canine model of left ventricular dysfunction. J Am Coll Cardiol 1994, 23:786–793.
Pouleur H, Hayashida W: Diastolic dysfunction and myocardial energetics. In Diastolic relaxation of the heart. Edited by Lorell BH, Grossman, W. Boston: Kluwer; 1994:277–282.
Neubauer S, Horn M, Cramer M, et al.: Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 1997, 96:2190–2196.
Cohn JN, Bristow MR, Chien KR, et al.: Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research. Circulation 1997, 95:766–770.
Dzeja PP, Vitkevicius KT, Redfield MM, et al.: Adenylate kinase-catalyzed phosphotransfer in the myocardium: increased contribution in heart failure. Circ Res 1999, 84:1137–1143. First study identifying adenylate kinase as an alternative phosphotransfer system in heart muscle, and providing measurements of energy fluxes through individual phosphotransfer reactions in failing myocardium.
O’Brien PJ, Gwathmey JK: Myocardial Ca 2+- and ATP-cycling imbalances in end-stage dilated and ischemic cardiomyopathies. Cardiovasc Res 1995, 30:394–404.
Heinke MY, Wheeler CH, Chang D, et al.: Protein changes observed in pacing-induced heart failure using two-dimensional electrophoresis. Electrophoresis 1998, 19:2021–2030.
Hayashi Y, Takeuchi M, Takaoka H, et al.: Alteration in energetics in patients with left ventricular dysfunction after myocardial infarction: increased oxygen cost of contractility. Circulation 1996, 93:932–939.
Panagia V, Lee SL, Singh A, et al.: Impairment of mitochondrial and sarcoplasmic reticular functions during the development of heart failure in cardiomyopathic (UM-X7.1) hamsters. Can J Cardiol 1986, 2:236–247.
Katz AM: Energy requirements of contraction and relaxation: implications for inotropic stimulation of the failing heart. Bas Res Cardiol 1989, 84:47–53.
Kalsi KK, Smolenski RT, Pritchard RD, et al.: Energetics and function of the failing human heart with dilated or hypertrophic cardiomyopathy. Eur J Clin Invest 1999, 29:469–477.
Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD: The release of cytochrome c from mitochondria: a primary site for bcl-2 regulation of apoptosis. Science 1997, 275:1132–1136.
Olivetti G, Abbi R, Quaini F, et al.: Apoptosis in the failing human heart. N Engl J Med 1997, 336:1131–1141.
Ottaway JH, Mowbray J: The role of compartmentation in the control of glycolysis. Curr Top Cell Reg 1977, 12:107–208.
Wallimann T, Wyss M, Brdiczka D, et al.: Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the "phosphocreatine circuit" for cellular energy homeostasis. Biochem J 1992, 28:21–40.
van Deursen J, Heerschap A, Oerlemans F, et al.: Skeletal muscle of mice deficient in muscle creatine kinase lack burst activity. Cell 1993, 74:621–631.
Tian R, Christe ME, Spindler M, et al.: Role of MgADP in the development of diastolic dysfunction in the intact beating rat heart. J Clin Invest 1997, 99:745–751.
Veksler VI, Kuznetsov AV, Anflous K, et al.: Muscle creatine kinase-deficient mice. Cardiac and skeletal muscles exhibit tissue-specific adaptation of the mitochondrial function. J Biol Chem 1995, 270:19921–19929.
Dzeja PP, Zeleznikar RJ, Goldberg ND: Suppression of creatine kinase-catalyzed phosphotransfer results in increased phosphoryl transfer by adenylate kinase in intact skeletal muscle. J Biol Chem 1996, 271:12847–12851.
Saupe KW, Spindler M, Tian R, Ingwall JS: Impaired cardiac energetics in mice lacking muscle-specific isoenzymes of creatine kinase. Circ Res 1998, 82:898–907. First study describing reduced energetic efficiency in creatine kinase-deficient transgenic hearts.
Steeghs K, Benders A, Oerlemans F, et al.: Altered Ca 2+ responses in muscles with combined mitochondrial and cytosolic creatine kinase deficiencies. Cell 1997, 89:93–103.
Nascimben L, Ingwall JS, Pauletto P, et al.: Creatine kinase system in failing and nonfailing human myocardium. Circulation 1996, 94:1894–1901.
Soboll S, Brdiczka D, Jahnke D, et al.: Octamer-dimer transitions of mitochondrial creatine kinase in heart disease. J Mol Cell Cardiol 1999, 31:857–866.
Robitaille PM, Merkle H, Sako E, et al.: Measurement of ATP synthesis rates by 31P-NMR spectroscopy in the intact myocardium in vivo. Mag Res Med 1990, 15:8–24.